InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,695.94
(
-0.96%
)
US TECH 100
19,286.00
(
0.01%
)
Dow Jones
41,954.24
(
-0.94%
)
Brent Oil
79.23
(
-2.11%
)
Bitcoin
62,308.06
(
0.14%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DB9

Send PM Follow Ignore
Followers 0
Posts 167
Boards Moderated 0
Alias Born 03/10/2007

DB9

Re: keitern post# 3004

Saturday, 03/10/2007 9:07:04 AM

Saturday, March 10, 2007 9:07:04 AM

Post# of 19309
Great News !!!


Phase II
Study of MM-093 to Treat Patients With Patients With Uveitis
This study is currently recruiting patients.
http://clinicaltrials.gov/ct/search;jsessionid=A26D0262BAB2EC25502B78A8E8582735?term=MM-093
Last Updated: March 7, 2007


Not yet on Merrimack Pharma!!
http://www.merrimackpharma.com/pipeline/index.html
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up